MISMATCH REPAIR DEFICIENCY
Clinical trials for MISMATCH REPAIR DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new MISMATCH REPAIR DEFICIENCY trials appear
Sign up with your email to follow new studies for MISMATCH REPAIR DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug combo aims to shrink tumors, spare women surgery
Disease control Not yet recruitingThis study is testing whether a combination of two immunotherapy drugs can shrink tumors enough to avoid surgery in women with a specific, surgically removable type of endometrial cancer. It will enroll about 30 women who have not had recent cancer treatment. The main goal is to …
Matched conditions: MISMATCH REPAIR DEFICIENCY
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Brain-Zapping ultrasound tested with drug in fight against recurrent cancer
Disease control Not yet recruitingThis is a small, early-stage study to see if a combination treatment is safe for people with a specific type of recurrent brain cancer (glioblastoma). Doctors will use a focused ultrasound device to target the tumor area along with an immunotherapy drug called pembrolizumab. The …
Matched conditions: MISMATCH REPAIR DEFICIENCY
Phase: PHASE1 • Sponsor: Jennifer Leddon • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC